Concepedia

Yvonne Pak

YP

Statistics

Publications

13

Citations

856

H-Index

13

Active since

1996

Affiliations

Portola Pharmaceuticals (United States)(Current)

University of Arizona

Oregon Health & Science University

AbbVie (United States)

Pharmacyclics (United States)

Yvonne Pak is an author at Portola Pharmaceuticals (United States) specializing in medicine, pharmacology, and oncology.

Top concepts

Publications per year

1996–2021

13

Publications

13

Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study

William G. Wierda, John N. Allan, Tanya Siddiqi et al. · Journal of Clinical Oncology · 2021 · 217 citations · Full text

PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model

Michael P. Reilly, Uma Sinha, Pierrette André et al. · Blood · 2010 · 131 citations · Full text

Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis

Greg Coffey, Francis DeGuzman, Mayuko Inagaki et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 116 citations

The Novel Kinase Inhibitor PRT062070 (Cerdulatinib) Demonstrates Efficacy in Models of Autoimmunity and B-Cell Cancer

Greg Coffey, Andreas Betz, Francis DeGuzman et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 89 citations

Sensitive and rapid isocratic liquid chromatography method for the quantitation of curcumin in plasma

Yvonne Pak, Renata Patek, Michael Mayersohn · Journal of Chromatography B · 2003 · 75 citations

, , +6

1–5 of 13